Showing 1 - 20 of 60 results
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
Frequently asked questions about ANSTO for the community.
ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.
ANSTO concluded an eventful National Science Week with a series of events celebrating how nuclear science and technology contributes to knowledge and progress.
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.
ANSTO commenced an aerosol sampling program thirty years ago this week to characterise these pollutants and ultimately, identify their sources, which has taken it to the forefront of environmental monitoring of this type in Australia and the region.
See details of previously published customer updates from our Health products team.
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
Radiation can be described as energy or particles from a source that travel through space or other mediums. Light, heat, and wireless communications are all forms of radiation.
Updated results show radiation therapy using lutetium-177 improved survival in advanced prostate cancer.
ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.
On average, there is now 17 per cent less rainfall across Western Australia’s south-western region than was recorded prior to 1970. This rainfall reduction has economic, social and environmental implications for the region, in particular for the growing capital of Perth, as well as water-dependent industries in the state.